“Addition of daratumumab to first-line therapy of newly diagnosed multiple myeloma in patients eligible for autologous stem cell transplantation: a single-center real-life experience”, Mediterr J Hematol Infect Dis, vol. 17, no. 1, p. e2025040, Apr. 2025, doi: 10.4084/MJHID.2025.040.